Y-Biologics (XKRX:338840) FCF Yield % : -6.36 (As of Sep. 22, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Y-Biologics's Trailing 12-Month Free Cash Flow is ₩-11,031 Mil, and Market Cap is ₩173,394 Mil. Therefore, Y-Biologics's FCF Yield % for today is -6.36%.

The historical rank and industry rank for Y-Biologics's FCF Yield % or its related term are showing as below:

XKRX:338840' s FCF Yield % Range Over the Past 10 Years
Min: -9.28 Med: -5.96 Max: -1.39
Current: -6.36

During the past 7 years, the highest FCF Yield % of Y-Biologics was -1.39%. The lowest was -9.28%. And the median was -5.96%.

XKRX:338840's FCF Yield % is ranked better than
65.19% of 1537 companies
in the Biotechnology industry
Industry Median: -13.28 vs XKRX:338840: -6.36

Y-Biologics's FCF Margin % for the quarter that ended in Jun. 2024 was -1,941.83%.

Y-Biologics FCF Yield % Historical Data

The historical data trend for Y-Biologics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics FCF Yield % Chart

Y-Biologics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-3.39

Y-Biologics Quarterly Data
	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
FCF Yield %	Get a 7-Day Free Trial					-	-	-5.17	-3.53	-12.70

Competitive Comparison of Y-Biologics's FCF Yield %

For the Biotechnology subindustry, Y-Biologics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Y-Biologics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Y-Biologics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Y-Biologics's FCF Yield % falls into.

Y-Biologics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Y-Biologics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-7803.273	/	230298.12
	=	-3.39%

Y-Biologics's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-4505.188	*	4	/	141934.895
	=	-12.70%

Y-Biologics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Y-Biologics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Y-Biologics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR

Website

https://www.ybiologics.com

Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics Headlines

No Headlines